ClinicalTrials.govpublic full text
Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis
chronic kidney diseases, calciphylaxis, calcific uremic arteriolopathy, treatment, safety, efficacy, human amniotic-derived mesenchymal stem cells, rare disease (orpha280062), interventional, early_phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1044271
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.